文献速递心外重症与机械循环支持

ECMO序贯全人工心脏桥接心脏移植的桥-桥策略

A bridge-to-bridge approach to heart transplantation using extracorporeal membrane oxygenation and total artificial heart.
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-09-20

本研究回顾性多中心分析54例心源性休克患者,先ECMO支持后植入临时全人工心脏(TAH-t)作为桥接,并与163例直接TAH-t桥接患者对照。结论认为ECMO序贯TAH-t再心脏移植是高度选择患者的可行选择。

要点

  • ECMO序贯TAH-t桥接心脏移植在高度选择患者中可行。
  • 两组TAH-t植入后死亡率及移植后生存率无显著差异。
  • TAH-t期间肝功能恶化与移植前死亡风险增加相关。

核心结论

  • ECMO序贯TAH-t再心脏移植是高度选择患者的可行桥接策略。

研究设计与样本

  • 回顾性多中心分析,ECMO-TAH-t组54例,TAH-t对照组163例。

主要发现

  • 移植后6个月、1年、3年生存率ECMO-TAH-t组为94%、87%、80%,TAH-t组为87%、83%、76%。
  • TAH-t支持期间死亡前三位原因为多器官衰竭(40%)、脓毒症(20%)、神经系统事件(20%)。
  • TAH-t期间胆红素、AST、ALT恶化与两组移植前死亡风险增加相关。

临床怎么用

  • 对高度选择的心源性休克患者,可考虑ECMO后过渡至TAH-t再行心脏移植。
  • TAH-t期间需监测肝功能,肝功能恶化提示移植前死亡风险增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aims to describe the outcomes after heart transplantation using a bridge-to-bridge strategy with a sequence of extracorporeal membrane oxygenation (ECMO) support followed by temporary total artificial heart implantation (TAH-t). METHODS: A retrospective, multicenter analysis of 54 patients who underwent TAH-t implantation following an ECMO for cardiogenic shock was performed (ECMO-TAH-t group). A control group of 163 patients who underwent TAH-t implantation as a direct bridge to transplantation (TAH-t group) was used to assess this strategy's impact on outcomes. RESULTS: Fifty-four patients, averaging 47 ± 13 year old, underwent implantation of a TAH-t after 5.3 ± 3.4 days of ECMO perfusion for cardiogenic shock. In the ECMO-TAH-t group, 20 patients (20/54%; 37%) died after TAH-t implantation and 57 patients (57/163%; 35%) died in the TAH-t group (Gray test; P = .49). The top 3 causes of death of patients on TAH-t support were multisystem organ failure (40%), sepsis (20%), and neurologic events (20%). Overall, 32 patients (32/54%; 59%) underwent heart transplantation in the ECMO-TAH-t group compared with 106 patients (106/163%, 65%) in the TAH-t group (P = .44). No significant difference in survival was observed at 6 months, 1 year, and 3 years after heart transplant (ECMO-TAH-t group: 94%, 87%, and 80% vs 87%, 83%, and 76% in the TAH-t group, respectively). Deterioration of liver function (bilirubin, aspartate transaminase, and alanine aminotransferase levels on TAH-t) was associated with increased mortality before heart transplant in both groups. CONCLUSIONS: Sequential bridging from ECMO to TAH-t followed by heart transplantation is a viable option for a group of highly selected patients.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Noly PE, Moriguchi J, Shah KB, et al. A bridge-to-bridge approach to heart transplantation using extracorporeal membrane oxygenation and total artificial heart. J Thorac Cardiovasc Surg. 2021. PMID: 34627602. doi:10.1016/j.jtcvs.2021.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。